GeneDx and Beren Therapeutics launch NPC GenomeComplete testing program
GeneDx announced a collaboration with Beren Therapeutics P.B.C. to launch the NPC GenomeComplete Sponsored Testing Program, offering no-cost comprehensive genome sequencing for eligible Niemann-Pick disease type C patients.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.